Abstract: The present invention relates to a process for the preparation of pure Paliperidone Palmitate, which comprises: (a) providing a solution of Paliperidone Palmitate in an alcoholic solvent; (b) adding the alcoholic solution of Paliperidone palmitate to water or vice versa; and (c) isolating the product to obtain pure Paliperidone Palmitate.

Abstract: A beverage dispenser ingredient level detection system is disclosed. The system may include a container with a wall, a canister, a capsule, an infrared emitter, and an infrared receiver. The canister may be disposed within the container at a first distance from the wall and may be configured to hold a beverage ingredient. The capsule may be disposed on an interior surface of the wall. The infrared emitter and the infrared receiver may be disposed within the capsule and the infrared receiver may be configured to transmit infrared light rays and the infrared receiver may be configured to detect infrared light rays reflected by the beverage ingredient in the canister to determine whether a pre-determined amount of the beverage ingredient is within the canister. The capsule may absorb infrared light rays that are not indicative of whether the pre-determined amount of the beverage ingredient is within the canister.

Abstract: The invention is directed to a process for recovering/purifying (meth)acrylic acid which does not use azeotropic solvent and is based on the use of two columns for purifying a reaction mixture comprising (meth)acrylic acid. The process according to the invention includes a dry vacuum pump condensation system, which makes it possible to reduce the amount of final aqueous discharges.

Abstract: The present invention relates to a method for treating a dry eye syndrome using an alpha 2 adrenergic agonist, pharmaceutically acceptable salt thereof or a mixture thereof. In particular, the alpha 2 adrenergic agonist of the invention has a higher alpha 2A agonist activity compared to alpha 2B agonist activity. This invention also relates to an ophthalmic composition comprising a therapeutically effective amount of an alpha 2 adrenergic agonist, a pharmaceutically acceptable salt thereof or a combination thereof as an active ingredient for treating a dry eye syndrome.

Abstract: Provided herein is a composition and a method for treating nucleic acid-related eye disease.

Abstract: The present invention relates to a process for the preparation of pure Paliperidone Palmitate, which comprises: (a) providing a solution of Paliperidone Palmitate in an alcoholic solvent; (b) adding the alcoholic solution of Paliperidone palmitate to water or vice versa; and (c) isolating the product to obtain pure Paliperidone Palmitate.

Abstract: The invention relates to the production of (meth)acrylic acid, and to implementation of a step of condensing water contained in a recycled gas effluent and/or in the air feed in a (meth)acrylic acid production process, which further includes a process for purifying a reaction mixture comprising (meth)acrylic acid without using azeotropic solvent and based on the use of two distillation columns.

Abstract: The invention relates to the production of (meth)acrylic acid, and to implementation of a step of condensing water contained in a recycled gas effluent and/or in the air feed in a (meth)acrylic acid production process, which further includes a process for purifying a reaction mixture comprising (meth)acrylic acid without using azeotropic solvent and based on the use of two distillation columns.

Abstract: The various embodiments herein provide a method and system for synchronization of links and attachments during synchronization between source and target devices. The system for executing synchronization between the source and target devices comprises a connector framework, a process framework, a mapping manager, a recovery manager, a conflict manager and a failure manager. The method comprises getting the “as of state” of the attachment that is old and new attachment information list for the revisions, then the system having history for the attachment constructs “as of state” and send as part of the event and system not having history for the attachment, stores attachment information in the history state table with the source update time information in poller as well as the time of adding attachment from the adapter.

Abstract: A system and method optimizes throughput of tracked assets as work-in-progress (WIP) within a monitored environment such as a manufacturing establishment with off-line processing areas. A plurality of assets such as vehicles have a tag transmitter associated therewith and operative for transmitting a wireless RF signal that includes data relating to the identification of the asset to which the tag transmitter is associated. A real-time location system (RTLS) infrastructure tracks the location of the plurality of assets to various containment, staging, and processing task areas within the monitored environment as WIP. A processor is operative with the RTLS infrastructure for determining an asset input rate into WIP at an origin to the WIP for optimizing asset flow rate as WIP through different containment, staging, and processing areas within the monitored environment.

Abstract: A beverage dispenser ingredient level detection system is disclosed. The system may include a container with a wall, a canister, a capsule, an infrared emitter, and an infrared receiver. The canister may be disposed within the container at a first distance from the wall and may be configured to hold a beverage ingredient. The capsule may be disposed on an interior surface of the wall. The infrared emitter and the infrared receiver may be disposed within the capsule and the infrared receiver may be configured to transmit infrared light rays and the infrared receiver may be configured to detect infrared light rays reflected by the beverage ingredient in the canister to determine whether a pre-determined amount of the beverage ingredient is within the canister. The capsule may absorb infrared light rays that are not indicative of whether the pre-determined amount of the beverage ingredient is within the canister.

Abstract: The present invention relates to a method for treating a dry eye syndrome using an alpha 2 adrenergic agonist, pharmaceutically acceptable salt thereof or a mixture thereof. In particular, the alpha 2 adrenergic agonist of the invention has a higher alpha 2A agonist activity compared to alpha 2B agonist activity. This invention also relates to an ophthalmic composition comprising a therapeutically effective amount of an alpha 2 adrenergic agonist, a pharmaceutically acceptable salt thereof or a combination thereof as an active ingredient for treating a dry eye syndrome.

Abstract: The present invention relates to the manufacture of biobased acrylic acid from glycerol as starting material, the term “biobased acid” indicating that the acrylic acid is essentially based on a carbon source of natural origin.

Abstract: Provided herein is a composition and a method for treating nucleic acid-related eye disease.

Abstract: A containerized architecture to secure and manage Internet-connected devices, such as “Internet of Things” devices, is disclosed. In various embodiments, one or more containerized applications are run, e.g., on an Internet of Things gateway, subject to management by the management server. At least one of the containerized applications is a management agent configured to participate, subject to control of the management server, in management of one or more other of said containerized applications.

Abstract: The present invention discloses pharmaceutical preparations for treatment of eye disorders containing an alpha 2 adrenergic agonist, to processes for producing the pharmaceutical preparations and methods for treatment of various eye disorders including dry eye and Meibomian gland dysfunction and a medicinal applicator for topical application of an alpha 2 adrenergic agonist to a subject, a package assembly for the medicinal applicator and methods of using the medicinal applicator to treat eye disorders.

Abstract: This invention relates to a process for producing natural oil based poly-urethane dispersion, in which the hydrophobic polyol comprising the prepolymer of the dispersion is made using a natural hydroxyl oil, which is converted or modified into pure poly-diols by selective capping or blocking at temperatures of less than 100° C., without using the process of esterification or alcoholysis for deriving such polyol. The resultant dispersion is substantially free of volatile organic chemicals and/or leachable contaminants, and is naturally biodegradable.

Abstract: The embodiments herein provide a method and system for polling and processing data. The method comprises computing a maximum time from a source after a last update time, waiting for a preset time to ensure that all transactions with respect to a change in a data is completed, querying for a plurality of changes after an elapse of the preset waiting time since the last update time and up to the maximum time, generating a time window, collecting a list of changes occurred within the generated time window, sending the collected list of changes for processing; and updating the processed data at the destination. The time window comprises a time interval between the last update time and the maximum time.

Abstract: The various embodiments herein disclose a system and method for generating a delta code coverage information. The system for generating delta code coverage information comprises, a source control module configured for storing a plurality of software program code files to be processed and a plurality of code coverage data corresponding to the plurality of software program code files, a processor configured to generate a delta code coverage data for analysis for each of the plurality of software program code files on a line level or at a branch level by performing a time based delta code coverage process and a path based delta code coverage process.